Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
Katherine R. Tuttle, Frank C. Brosius, Sharon G. Adler, et al.
Nephrology Dialysis Transplantation (2017) Vol. 33, Iss. 11, pp. 1950-1959
Open Access | Times Cited: 232

Showing 1-25 of 232 citing articles:

The JAK/STAT signaling pathway: from bench to clinic
Xiaoyi Hu, Jing Li, Maorong Fu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1464
Macrophages: versatile players in renal inflammation and fibrosis
Patrick Ming‐Kuen Tang, David J. Nikolic‐Paterson, Hui Y. Lan
Nature Reviews Nephrology (2019) Vol. 15, Iss. 3, pp. 144-158
Closed Access | Times Cited: 748
Epigenetics and epigenomics in diabetic kidney disease and metabolic memory
Mitsuo Kato, Rama Natarajan
Nature Reviews Nephrology (2019) Vol. 15, Iss. 6, pp. 327-345
Open Access | Times Cited: 446
Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease
Paul M. Ridker, Manas Rane
Circulation Research (2021) Vol. 128, Iss. 11, pp. 1728-1746
Open Access | Times Cited: 439
Metabolic Inflammation and Insulin Resistance in Obesity
Huaizhu Wu, Christie M. Ballantyne
Circulation Research (2020) Vol. 126, Iss. 11, pp. 1549-1564
Open Access | Times Cited: 427
Innate immunity in diabetic kidney disease
Sydney C.W. Tang, Wai Han Yiu
Nature Reviews Nephrology (2020) Vol. 16, Iss. 4, pp. 206-222
Closed Access | Times Cited: 399
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
Ralph A. DeFronzo, William Reeves, Alaa S. Awad
Nature Reviews Nephrology (2021) Vol. 17, Iss. 5, pp. 319-334
Closed Access | Times Cited: 392
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
Hiddo J.L. Heerspink, Paul Perco, Skander Mulder, et al.
Diabetologia (2019) Vol. 62, Iss. 7, pp. 1154-1166
Open Access | Times Cited: 367
A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes
Monika A. Niewczas, Meda E. Pavkov, Jan Skupień, et al.
Nature Medicine (2019) Vol. 25, Iss. 5, pp. 805-813
Open Access | Times Cited: 330
Emerging Targets in Type 2 Diabetes and Diabetic Complications
Sevgican Demir, Peter P. Nawroth, Stephan Herzig, et al.
Advanced Science (2021) Vol. 8, Iss. 18
Open Access | Times Cited: 325
Molecular mechanisms and therapeutic targets for diabetic kidney disease
Katherine R. Tuttle, Rajiv Agarwal, Charles E. Alpers, et al.
Kidney International (2022) Vol. 102, Iss. 2, pp. 248-260
Open Access | Times Cited: 309
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Yiwen Li, Yanfei Liu, Shiwei Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 250
Inflammation in Diabetic Kidney Disease
Rosa Elena Pérez-Morales, María Dolores del Pino y Pino, José Manuel Valdivielso, et al.
˜The œNephron journals/Nephron journals (2018) Vol. 143, Iss. 1, pp. 12-16
Closed Access | Times Cited: 244
Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
Sandra Rayego‐Mateos, José Luis Morgado‐Pascual, Lucas Opazo-Ríos, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3798-3798
Open Access | Times Cited: 223
Signaling pathways of chronic kidney diseases, implications for therapeutics
Qian Yuan, Ben Tang, Chun Zhang
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 220
Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies
Annabelle M. Warren, Søren Tang Knudsen, Mark E. Cooper
Expert Opinion on Therapeutic Targets (2019) Vol. 23, Iss. 7, pp. 579-591
Closed Access | Times Cited: 216
Inflammatory Targets in Diabetic Nephropathy
Javier Donate‐Correa, Desirée Luis-Rodríguez, Ernesto Martín‐Núñez, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 2, pp. 458-458
Open Access | Times Cited: 180
Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease
Keiichiro Matoba, Yusuke Takeda, Yosuke Nagai, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 14, pp. 3393-3393
Open Access | Times Cited: 173
Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function
Eoin Brennan, Phillip Kantharidis, Mark E. Cooper, et al.
Nature Reviews Nephrology (2021) Vol. 17, Iss. 11, pp. 725-739
Open Access | Times Cited: 156
Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments
Samar A. Antar, Nada A. Ashour, Marwa Sharaky, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115734-115734
Open Access | Times Cited: 150
Single cell transcriptomics identifies focal segmental glomerulosclerosis remission endothelial biomarker
Rajasree Menon, Edgar A. Otto, Paul Hoover, et al.
JCI Insight (2020) Vol. 5, Iss. 6
Open Access | Times Cited: 142
Diabetic Kidney Disease: Challenges, Advances, and Opportunities
Ya Chen, Kyung Lee, Zhaohui Ni, et al.
Kidney Diseases (2020) Vol. 6, Iss. 4, pp. 215-225
Open Access | Times Cited: 141
Signaling Pathways Involved in Diabetic Renal Fibrosis
Yuqing Zhang, De Jin, Xiaomin Kang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 141
TGF-Beta as a Master Regulator of Diabetic Nephropathy
Li Wang, Honglian Wang, Tong‐Tong Liu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7881-7881
Open Access | Times Cited: 121
Mechanisms of podocyte injury and implications for diabetic nephropathy
Federica Barutta, Stefania Bellini, Gabriella Gruden
Clinical Science (2022) Vol. 136, Iss. 7, pp. 493-520
Open Access | Times Cited: 116
Page 1 - Next Page

Scroll to top